1ST.AX stock surges 22% in May 2026 pre-market trading on ASX

1ST.AX stock is making waves in pre-market trading on May 5, 2026, with a 22.2% surge that has caught investor attention on the ASX. The healthcare services company, 1st Group Limited, climbed to A$0.011 per share as trading volume spiked to 2.07 million shares, significantly above its average daily volume of 678,621. This jump reflects renewed interest in the Sydney-based firm, which operates MyHealth1st.com.au, PetYeti, and GoBookings.com platforms. The company serves pharmacies, medical practices, vets, and corporate clients across Australia. We’ll examine what’s driving this pre-market momentum and what it means for investors tracking this healthcare technology player.

1ST.AX Stock Price Movement and Trading Activity

The 22.2% gain represents a significant move for 1ST.AX, pushing the stock from its previous close of A$0.009 to A$0.011. Trading volume surged to 2.07 million shares, delivering a relative volume ratio of 3.06 times the average, indicating strong institutional and retail participation.

The stock remains well below its 52-week high of A$0.015 but has recovered substantially from its 52-week low of A$0.004. The market cap stands at A$15.59 million with 1.42 billion shares outstanding. Track 1ST.AX on Meyka for real-time updates on price movements and trading patterns throughout the session.

Market Sentiment and Technical Positioning

Pre-market strength often signals investor confidence heading into the regular session. The 3.06x relative volume suggests this isn’t random retail buying but coordinated interest in the stock.

Trading Activity: Volume spike indicates institutional players may be positioning ahead of announcements or earnings updates. The stock’s 50-day moving average sits at A$0.00917, while the 200-day average is A$0.00796, showing the stock trades above both key technical levels.

Liquidation Signals: Positive pre-market momentum typically reduces selling pressure at the open. The strong volume without price rejection suggests buyers are absorbing supply confidently, a bullish technical signal for the regular session.

1st Group Limited Business Model and Market Position

1st Group Limited operates three core platforms serving Australia’s healthcare and corporate sectors. MyHealth1st.com.au functions as a health services marketplace connecting patients with providers. PetYeti serves the veterinary market with online booking and services. GoBookings.com targets corporate and government clients with SaaS solutions.

The company also develops proprietary telehealth software and diagnostic devices that integrate with medical practice systems. CEO Josh Mundey leads the Sydney-based firm, which was incorporated in 2009 and listed on the ASX in June 2015. The Healthcare sector on the ASX has shown mixed performance, with an average PE of 26.9 and sector-wide challenges in profitability metrics.

Financial Metrics and Valuation Context

1ST.AX carries a negative PE ratio of -3.95, reflecting current operating losses. The price-to-sales ratio of 3.49 suggests the market values the company at a modest multiple relative to revenue generation. Meyka AI rates 1ST.AX with a grade of B, suggesting a HOLD recommendation based on comprehensive analysis.

This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company generated revenue per share of A$0.0034 TTM but posted a net loss per share of A$0.0028. Meyka AI’s forecast model projects the stock could reach A$0.0072 within one year, implying 35% upside from current levels. Forecasts are model-based projections and not guarantees.

Final Thoughts

1ST.AX surged 22.2% in pre-market trading, driven by renewed investor interest in 1st Group Limited’s healthcare technology platforms. High trading volume signals strong participation. Despite profitability challenges, the company’s diversified digital healthcare services position it well in a growing market. Meyka AI’s B-grade rating and A$0.0072 forecast reflect cautious optimism. Investors should monitor earnings and platform adoption metrics closely. While pre-market strength is encouraging, sustained momentum requires fundamental improvements in cash flow and profitability.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.